Collaborative and Multidisciplinary Pilot Research (CaMPR) Pilot Award

This service is provided by the Pilot and Collaborative Studies Resource (PCSR).

Overview

The Collaborative and Multidisciplinary Pilot Research Pilot Award (CaMPR) is a two-phase award that provides planning and start-up funds to support the formation of newly-configured investigative teams with the aim of addressing a significant health problem at the cellular, individual, or community level.

Phase I: Planning Grant

  • Duration: Three months
  • Award amount: $15,000
  • Number of grants: Approximately four planning grants per year

The planning grant supports:

  1. Identification and assembly of a newly-configured multidisciplinary team with expertise in diverse methodologies
  2. Design, development, and submission of a pilot grant proposal by the end of the three-month grant period

The Phase I planning grant application should be about planning and development. It is NOT a proposal based on preliminary data or guided by a well-crafted set of specific aims and testable hypotheses at the time of submission. Although each team should have identified an addressable health problem in need of an innovative solution and a few key members of the team to start the planning process, the overall aims and direction of planning activities should be somewhat general at the time of submission. It is expected that the final set of team members, methods, and approaches will evolve in the early months as the team consolidates, generates new ideas, and benefits from interaction and new insights. Applicants should not propose to use Phase I funds to obtain preliminary data for Phase II.

Criteria for selection include innovation, public health impact, meaningful involvement of junior investigators, and likelihood that the pilot proposal will progress to an NIH proposal. Past winners have proposed activities related to team identification and assembly, group communication strategies, off-site consultation visits, and state-of-the-science meetings.

Phase II: Pilot Award

  • Duration: One year
  • Award amount: $75,000
  • Number of awards: Approximately two awards per year

Two of the four Phase I awardees will be selected to receive a one-year award to support pilot work with the clear goal of submitting an NIH proposal. A final report is due at the end of the grant year. The pilot award will be granted to those who best meet the following goals of the CaMPR award program:

  • Establish newly-configured, multidisciplinary investigative teams involving both senior and junior faculty from at least two of the four Columbia University Irving Medical Center (CUIMC) schools (see eligibility section for details)
  • Train and mentor a new generation of clinical/translational investigators
  • Expand and optimize the utilization of new and existing resources at CUIMC
  • Address a significant public health problem using novel, multidisciplinary approaches
  • Produce pilot data that are likely to lead to a major grant funded by the NIH or other public or private agency

See a list of current and past CaMPR planning grant and pilot award recipients here.

Eligibility

  • Applicants (principal investigator(s)) must have a faculty appointment at CUIMC of assistant professor or higher in either the clinical or tenure track (includes those on the research scientist track) at the time of award.
  • Postdoctoral fellows are not eligible to apply.
  • Each team must be composed of at least one junior/senior mentorship pair and other collaborators who have not previously worked together in a substantive way.
  • Teams may include no more than six investigators.
  • Teams must represent at least one of the CUIMC schools (Vagelos College of Physicians and Surgeons, College of Dental Medicine, School of Nursing, Mailman School of Public Health); investigators from the NewYork-Presbyterian Hospital as well as other disciplines and schools from the Morningside and Manhattanville Campuses (e.g. Fu Foundation School of Engineering, School of Social Work) may represent the second school.
  • Although senior leaders of the Irving Institute may be consulted during the preparation of the application, they should not be listed as co-investigators or collaborators.
  • Teams may include outside consultants with unique experience or expertise in innovative approaches not currently available at CUIMC.
  • Applicants for the Phase II cycle must have received one of the four Phase I planning grants.

Potential collaborators can be searched by keyword or by name through Columbia University Scientific Profiles (CUSP).

Deadlines

Applications for the CaMPR Phase I will be accepted in fall, 2019.

It is strongly recommended that interested applicants schedule a pilot funding eligibility consultation before beginning the phase I application process.

Cite it, Submit it, Share it!

If your research has benefited from one or more Irving Institute resources, please remember to:

  • Cite our CTSA grant, UL1 TR001873, in any relevant publications, abstracts, chapters, and/or posters.
  • Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy.
  • Share your research updates with us by sending an email to: irving_institute@cumc.columbia.edu

Contact

Michelle McClave
622 West 168th Street, 10th Floor
New York, NY 10032
United States